Cargando…
589. Use of Dalbavancin in Facilitating Discharge of High Risk Patients in Low Resource Settings
BACKGROUND: Patients who inject intravenous drugs (PWID) can have devastating infections with poor outcomes while being burdensome to the healthcare system, both in terms of lack of payment and length of stay. These issues are only exacerbated in settings where addiction treatment resources such as...
Autor principal: | Milgrom, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777697/ http://dx.doi.org/10.1093/ofid/ofaa439.783 |
Ejemplares similares
-
122. Dalbavancin Use in Patients with Substance Use Disorders
por: Streifel, Amber C, et al.
Publicado: (2020) -
754. Evaluation of Standardized Dalbavancin Use to Facilitate Early Hospital Discharge for Patients Inappropriate for Outpatient Parenteral Antibiotic Therapy
por: Shihadeh, Katherine C, et al.
Publicado: (2019) -
614. Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2021) -
599. Dalbavancin Utilization in Rural Healthcare Setting: A Single Center Three Years’ Experience
por: AlSalman, Ahmad, et al.
Publicado: (2020) -
2380. Healthcare Resource Utilization for High-Risk Patients Treated With Dalbavancin in Physician Office Infusion Centers (POICs)
por: Luu, Quyen, et al.
Publicado: (2018)